Top Abstract Purchase Related
Home
>
Node
>
Subnode

Maintenance therapy of mild form of GERD by H2 receptor antagonists

Kurosawa, S.

Nihon Rinsho. Japanese Journal of Clinical Medicine 58(9): 1859-1864

2000

ISSN/ISBN: 0047-1852
PMID: 11004816
Document Number: 525012
Because of high relapse rate after the healing by proton pump inhibitor(PPI) or H2 receptor antagonist(H2RA), GERD usually needs long time maintenance therapy. PPI is superior to H2RA in the first line as well as maintenance therapy. PPI is necessary for severe cases of GERD. However, H2RA is sufficient for milder form of GERD patients. Among the H2RA using in Japan, nizatidine has known to stimulate gastric emptying and elevate LES pressure. Nizatidine may be superior to other H2RAs in the treatment of GERD. Recently, nocturnal acid breakthrough which night time acid is secreted even PPI is administered twice daily has been documented. H2RAs are stronger than PPI to inhibit nocturnal acid breakthrough and may be better than night time acid reflux.

Document emailed within 1 workday
Secure & encrypted payments

Minushkin, O.N.; Maslovskiĭ, L.V.; Anikina, N.I.; Shuleshova, A.G. 2005: Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1 Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 29-35
Kessler, S.; Kessler, D.; Frishman, W.H. 1999: Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists Drugs of Today 35(6): 413-418
Bjermer, L.; Diamant, Z. 2002: The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma Monaldi Archives for Chest Disease 57(1): 76-83
Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
Pace, F. 2007: A new questionnaire for evaluation of GERD symptoms. GERD Impacte Scale Recenti Progressi in Medicina 98(12): 633-637
Nielsen, S.T.; Dove, P.A.; Strike, D.P.; Schiehser, G.A. 1987: Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity Drugs under Experimental and Clinical Research 13(5): 297-304
Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432
Olivennes, F. 2004: Déclenchement par agonistes de la GnRH ou hCG et soutien de la phase lutéale dans les cycles sous antagonistes de la GnRH - Onset and maintenance of the luteal phase with GnRH antagonists or hCG in cycles under GnRH antagonists Journal de Gynecologie Obstetrique et Biologie de la Reproduction 33(6): 3S 24-3S 26
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Fanelli, R.D.; Gersin, K.S.; Bakhsh, A. 2003: The Stretta procedure: effective endoluminal therapy for GERD Surgical Technology International 11: 129-134
Desai, M.A.; Burnett, J.P.; Ornstein, P.L.; Schoepp, D.D. 1995: Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists Journal of Pharmacology and Experimental Therapeutics 272(1): 38-43
Romano, S.; Iodice, P.; Mercone, G.; Ferlito, G.; Corsini, G.; Correale, E.; Tritto, C. 1986: Vectorcardiogram (VCG) in the identification of mild-form ventricular pre-excitation Minerva Cardioangiologica 34(10): 641-647
Block, C.M. 1996: Implant identification card and maintenance form Implant Society: 6(2): 9-10
Jokanović, R.; Nikezić, M.; Zujović, J.; Bumbić, S.; Necić, S. 1975: Mild form of Hirschsprung's disease in a boy with idiopathic diabetes insipidus Srpski Arhiv Za Celokupno Lekarstvo 103(10): 877-882
Kocsis, S.G. 1994: A single central maxillary incisor in the midline as a mild form of holoprosencephaly Fogorvosi Szemle 87(3): 63-70
Rechkin, V.I. 1973: Clinical characteristics of the mild form of hemorrhagic fever with the kidney syndrome Voenno-Meditsinskii Zhurnal 5: 48-52
Annibale, B.; Franceschi, M.; Fusillo, M.; Beni, M.; Cesana, B.; Delle Fave, G. 1998: Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment Hepato-Gastroenterology 45(21): 742-751
Mazurat, R.D.; Wood, J.E.; Love, W.B. 1994: The role of the restorative dentist in the diagnosis and maintenance phases of implant therapy--Part III: The restoration and maintenance of oral health prior to the provision of the implant prosthesis Journal 60(9): 819-821
Ishmatov, I.M. 1990: Changes in various biophysical parameters of blood circulation during physical exertion in patients with a mild form of hypertension Kardiologiia 30(7): 16-18
Saller, C.F.; Czupryna, M.J.; Salama, A.I. 1990: 5-HT2 receptor blockade by ICi 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade Journal of Pharmacology and Experimental Therapeutics 253(3): 1162-1170